Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 13,000 | |||
25 mg | 在庫あり | ¥ 21,500 | |||
50 mg | 在庫あり | ¥ 35,000 | |||
100 mg | 在庫あり | ¥ 58,000 | |||
500 mg | 在庫あり | ¥ 145,000 |
説明 | SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role. |
別名 | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid |
分子量 | 281.33 |
分子式 | C13H15NO4S |
CAS No. | 1695562-36-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (195.5 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SXC 2023 1695562-36-7 Others SXC2023 SXC-2023 2-acetamido-3-(4-methylbenzoylthio)propanoic acid (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid Inhibitor inhibitor inhibit